OGXI

OncoGenex Pharmaceuticals Inc. News Headlines

$2.01
*  
0.01
0.5%
Get OGXI Alerts
*Delayed - data as of Jan. 30, 2015  -  Find a broker to begin trading OGXI now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
OncoGenex's AFFINITY on Track, Passes Futility Analysis - Analyst Blog
1/19/2015 4:10:00 PM - Zacks.com


OncoGenex's AFFINITY on Track, Passes Futility Analysis - Analyst Blog
1/19/2015 4:10:00 AM - Investopedia


Biotech Weekly: Top Value Biotech Picks For 2015
1/5/2015 9:01:00 AM - Seeking Alpha


Seeking Alpha's Biotech Weekly: 2014's Approval-Palooza, Ebola In Scotland, And More
1/2/2015 4:00:00 PM - Seeking Alpha


OncoGenex to End Deal with Teva & Regain Custirsen Rights - Analyst Blog
12/31/2014 2:55:00 PM - Investopedia


OncoGenex to End Deal with Teva & Regain Custirsen Rights - Analyst Blog
12/31/2014 2:55:00 PM - Zacks.com


Health Care Sector Update for 12/30/2014: ARIA, OGXI, NDRM, IDRA
12/30/2014 8:47:28 AM - MT Newswires


OncoGenex Pharma To Regain Rights To Custirsen From Teva Pharmaceutical
12/30/2014 8:11:00 AM - RTT News


OncoGenex To Regain Rights To Custirsen From Teva - Quick Facts
12/30/2014 7:09:00 AM - RTT News


Value Remains At OncoGenex After Borealis-1
12/26/2014 9:00:00 AM - Seeking Alpha


OncoGenex's Pancreatic Cancer Study Fully Enrolled - Analyst Blog
12/17/2014 3:10:00 PM - Zacks.com


OncoGenex's Pancreatic Cancer Study Fully Enrolled - Analyst Blog
12/17/2014 3:10:00 AM - Investopedia


OncoGenex: Deep Pipeline For Microcap Offers Significant Upside
12/10/2014 10:11:00 AM - Seeking Alpha


OncoGenex Pharma To Present At Stifel Healthcare Conference; Webcast At 10:55 AM
11/19/2014 9:55:00 AM - RTT News


Isis Pharmaceuticals Inc. Strikes Out on Its Own
11/7/2014 2:30:27 PM - Motley Fool


Biotech Watchlist Update: Small-Cap Biotechs Struggle, But Investors Remain Enchanted By Big Pharma's Returns
11/7/2014 9:16:00 AM - Seeking Alpha


OncoGenex's Phase III Prostate Cancer Study Fully Enrolled - Analyst Blog
9/18/2014 4:11:00 PM - Zacks.com


OncoGenex's Custirsen Passes First Interim Futility Analysis - Analyst Blog
8/22/2014 4:40:00 PM - Zacks.com


Sector Update: Health Care Stocks Mixed; OncoGenex Pharmaceuticals Climbs After Cancer Drug Wins Fast-Track Designation
8/22/2014 11:47:28 AM - MT Newswires


Sector Update: Health Care
8/22/2014 11:46:48 AM - MT Newswires


OncoGenex Q2 Loss Narrower than Expected, Revenues Down Y/Y - Analyst Blog
8/8/2014 3:00:00 PM - Zacks.com


OncoGenex Pharmaceuticals (OGXI) Soars: Stock Up 8.2% - Tale of the Tape
8/8/2014 8:39:00 AM - Zacks.com


OncoGenex's Apatorsen in Phase II for Lung Cancer - Analyst Blog
7/7/2014 3:30:00 PM - Zacks.com


Basket Of Biotech Bargains To Buy And Hold
6/30/2014 4:23:00 PM - Seeking Alpha


Moving Average Crossover Alert: OncoGenex (OGXI) - Tale of the Tape
5/21/2014 7:18:51 AM - Zacks.com